Provided by Tiger Trade Technology Pte. Ltd.

BridgeBio Pharma, Inc.

72.50
-3.5800-4.71%
Post-market: 74.001.50+2.07%18:57 EDT
Volume:3.06M
Turnover:223.68M
Market Cap:14.20B
PE:-20.32
High:75.50
Open:75.27
Low:72.12
Close:76.08
52wk High:93.42
52wk Low:48.78
Shares:195.81M
Float Shares:167.00M
Volume Ratio:1.77
T/O Rate:1.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5686
EPS(LYR):-3.7850
ROE:-1789.67%
ROA:-26.00%
PB:-5.64
PE(LYR):-19.15

Loading ...

BridgeBio announces FDA acceptance, priority review of BBP-418 NDA

TIPRANKS
·
May 27

BridgeBio Pharma Says FDA Accepts Muscular Dystrophy Drug Application for Priority Review

MT Newswires Live
·
May 27

BridgeBio says FDA accepts BBP-418 NDA for LGMD2I/R9, grants priority review

Reuters
·
May 27

BridgeBio Announces FDA Acceptance and Priority Review of Nda for Bbp-418 for Lgmd2i/R9

THOMSON REUTERS
·
May 27

BridgeBio Pharma Inc - FDA Sets Pdufa Target Action Date of November 27, 2026 for Bbp-418

THOMSON REUTERS
·
May 27

BridgeBio Pharma Inc - FDA Not Planning Advisory Committee Meeting for Bbp-418 Application

THOMSON REUTERS
·
May 27

BridgeBio CEO Neil Kumar sells BBIO shares worth $1.73 million

Reuters
·
May 27

BridgeBio Pharma Inc : Raymond James Cuts to Market Perform From Outperform

THOMSON REUTERS
·
May 26

U.S. RESEARCH ROUNDUP-Apollo, Phillips 66, Valero Energy

Reuters
·
May 26

BridgeBio Pharma (BBIO) Gets a Hold from Citi

TIPRANKS
·
May 20

Analysts Offer Insights on Healthcare Companies: BridgeBio Pharma (BBIO) and Cullinan Management (CGEM)

TIPRANKS
·
May 20

BridgeBio Pharma President, CFO Thomas Trimarchi disposes of USD 2.41 million shares

Reuters
·
May 20

BridgeBio director Randal W. Scott sells USD 655,873 in common shares

Reuters
·
May 20

BridgeBio Pharma Initiated at Neutral by Citigroup

Dow Jones
·
May 19

U.S. RESEARCH ROUNDUP-Costco Wholesale, HCA Healthcare, Micron Technology

Reuters
·
May 19

BridgeBio initiated with a Neutral at Citi

TIPRANKS
·
May 19

Stock Track | BridgeBio Pharma Soars 5.02% Intraday on Analyst Bullishness

Stock Track
·
May 14

Analysts Are Bullish on These Healthcare Stocks: BridgeBio Pharma (BBIO), Palisade Bio (PALI)

TIPRANKS
·
May 13

BridgeBio Oncology Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

BridgeBio Oncology awards employee stock options for 32,675 shares at $7.66

Reuters
·
May 13